Shares of Xos, Inc. (NASDAQ:XOS – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six ratings firms that are covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among analysts that have covered the stock in the last year is $10.25.
Several research firms have recently issued reports on XOS. Roth Capital upgraded XOS to a “strong-buy” rating in a research note on Wednesday, October 23rd. Northland Securities reiterated a “market perform” rating and set a $5.00 price target (down previously from $9.00) on shares of XOS in a report on Monday, November 25th. Northland Capmk cut shares of XOS from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 25th. Finally, Roth Mkm started coverage on shares of XOS in a report on Wednesday, October 23rd. They set a “buy” rating and a $15.00 price objective for the company.
Read Our Latest Research Report on XOS
Insiders Place Their Bets
XOS Trading Down 5.5 %
Shares of NASDAQ:XOS opened at $3.25 on Thursday. XOS has a 1 year low of $3.25 and a 1 year high of $14.86. The firm has a fifty day moving average price of $4.29 and a 200 day moving average price of $5.28. The stock has a market capitalization of $26.10 million, a PE ratio of -0.49 and a beta of 1.77.
About XOS
Xos, Inc designs, manufactures, and sells battery-electric commercial vehicles. The company provides class 5-6 medium duty rolling chassis, such as commercial stepvans and armored trucks; class 7-8 heavy duty chassis; and Xos product development. It offers Xos provides mix-use powertrain solutions for off-highway, industrial and other commercial equipment, and specialty vehicles, such as school buses, medical and dental clinics, blood donation vehicles, and mobile command vehicles.
Featured Stories
- Five stocks we like better than XOS
- Manufacturing Stocks Investing
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Differences Between Momentum Investing and Long Term Investing
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for XOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOS and related companies with MarketBeat.com's FREE daily email newsletter.